Home Healthcare Pharmaceuticals Psoriasis Drug Market

Psoriasis Drug Market Size, Share & Trends Analysis Report By Class Type (Tumor Necrosis Factor Inhibitors, Interleukin Inhibitors, Vitamin D Analogues, Corticosteroids, Others), By Treatment Type (Biologics, Corticosteroids, Vitamin D Analogs, Others), By Route of Administration (Parenteral, Oral, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacie, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: March 18, 2026 | Author: Debashree B | Format: | Report Code: SR500DR | Pages: 150
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Psoriasis Drug Market, By Class Type 2022-2034 (USD MILLION/ Units)
    1. Tumor Necrosis Factor Inhibitors
    2. Interleukin Inhibitors
    3. Vitamin D Analogues
    4. Corticosteroids
    5. Others
  2. Psoriasis Drug Market, By Treatment Type 2022-2034 (USD MILLION/ Units)
    1. Biologics
    2. Corticosteroids
    3. Vitamin D Analogs
    4. Others
  3. Psoriasis Drug Market, By Route of Administration 2022-2034 (USD MILLION/ Units)
    1. Parenteral
    2. Oral
    3. Topical
  4. Psoriasis Drug Market, By Distribution Channel 2022-2034 (USD MILLION/ Units)
    1. Hospital Pharmacies
    2. Retail Pharmacie
    3. Others
  5. Regional Psoriasis Drug Market
    1. North America
      1. North America Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      2. North America Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Biologics
        2. Corticosteroids
        3. Vitamin D Analogs
        4. Others
      3. North America Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. North America Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacie
        3. Others
      5. U.S. Psoriasis Drug Market
        1. U.S. Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. U.S. Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Biologics
          2. Corticosteroids
          3. Vitamin D Analogs
          4. Others
        3. U.S. Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        4. U.S. Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacie
          3. Others
      6. Canada Psoriasis Drug Market
        1. Canada Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Canada Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Biologics
          2. Corticosteroids
          3. Vitamin D Analogs
          4. Others
        3. Canada Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        4. Canada Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacie
          3. Others
    2. Europe
      1. Europe Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      2. Europe Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Biologics
        2. Corticosteroids
        3. Vitamin D Analogs
        4. Others
      3. Europe Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Europe Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacie
        3. Others
      5. U.K. Psoriasis Drug Market
        1. U.K. Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. U.K. Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Biologics
          2. Corticosteroids
          3. Vitamin D Analogs
          4. Others
        3. U.K. Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        4. U.K. Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacie
          3. Others
      6. Germany Psoriasis Drug Market
        1. Germany Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Germany Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Biologics
          2. Corticosteroids
          3. Vitamin D Analogs
          4. Others
        3. Germany Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        4. Germany Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacie
          3. Others
      7. France Psoriasis Drug Market
        1. France Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. France Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Biologics
          2. Corticosteroids
          3. Vitamin D Analogs
          4. Others
        3. France Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        4. France Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacie
          3. Others
      8. Spain Psoriasis Drug Market
        1. Spain Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Spain Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Biologics
          2. Corticosteroids
          3. Vitamin D Analogs
          4. Others
        3. Spain Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        4. Spain Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacie
          3. Others
      9. Italy Psoriasis Drug Market
        1. Italy Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Italy Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Biologics
          2. Corticosteroids
          3. Vitamin D Analogs
          4. Others
        3. Italy Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        4. Italy Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacie
          3. Others
      10. Russia Psoriasis Drug Market
        1. Russia Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Russia Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Biologics
          2. Corticosteroids
          3. Vitamin D Analogs
          4. Others
        3. Russia Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        4. Russia Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacie
          3. Others
      11. Nordic Psoriasis Drug Market
        1. Nordic Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Nordic Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Biologics
          2. Corticosteroids
          3. Vitamin D Analogs
          4. Others
        3. Nordic Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        4. Nordic Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacie
          3. Others
      12. Benelux Psoriasis Drug Market
        1. Benelux Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Benelux Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Biologics
          2. Corticosteroids
          3. Vitamin D Analogs
          4. Others
        3. Benelux Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        4. Benelux Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacie
          3. Others
      13. Rest of Europe Psoriasis Drug Market
        1. Rest of Europe Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Rest of Europe Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Biologics
          2. Corticosteroids
          3. Vitamin D Analogs
          4. Others
        3. Rest of Europe Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        4. Rest of Europe Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacie
          3. Others
    3. APAC
      1. APAC Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      2. APAC Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Biologics
        2. Corticosteroids
        3. Vitamin D Analogs
        4. Others
      3. APAC Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. APAC Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacie
        3. Others
      5. China Psoriasis Drug Market
        1. China Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. China Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Biologics
          2. Corticosteroids
          3. Vitamin D Analogs
          4. Others
        3. China Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        4. China Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacie
          3. Others
      6. Korea Psoriasis Drug Market
        1. Korea Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Korea Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Biologics
          2. Corticosteroids
          3. Vitamin D Analogs
          4. Others
        3. Korea Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        4. Korea Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacie
          3. Others
      7. Japan Psoriasis Drug Market
        1. Japan Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Japan Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Biologics
          2. Corticosteroids
          3. Vitamin D Analogs
          4. Others
        3. Japan Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        4. Japan Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacie
          3. Others
      8. India Psoriasis Drug Market
        1. India Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. India Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Biologics
          2. Corticosteroids
          3. Vitamin D Analogs
          4. Others
        3. India Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        4. India Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacie
          3. Others
      9. Australia Psoriasis Drug Market
        1. Australia Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Australia Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Biologics
          2. Corticosteroids
          3. Vitamin D Analogs
          4. Others
        3. Australia Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        4. Australia Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacie
          3. Others
      10. Singapore Psoriasis Drug Market
        1. Singapore Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Singapore Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Biologics
          2. Corticosteroids
          3. Vitamin D Analogs
          4. Others
        3. Singapore Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        4. Singapore Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacie
          3. Others
      11. Taiwan Psoriasis Drug Market
        1. Taiwan Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Taiwan Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Biologics
          2. Corticosteroids
          3. Vitamin D Analogs
          4. Others
        3. Taiwan Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        4. Taiwan Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacie
          3. Others
      12. South East Asia Psoriasis Drug Market
        1. South East Asia Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. South East Asia Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Biologics
          2. Corticosteroids
          3. Vitamin D Analogs
          4. Others
        3. South East Asia Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        4. South East Asia Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacie
          3. Others
      13. Rest of Asia-Pacific Psoriasis Drug Market
        1. Rest of Asia-Pacific Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Rest of Asia-Pacific Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Biologics
          2. Corticosteroids
          3. Vitamin D Analogs
          4. Others
        3. Rest of Asia-Pacific Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        4. Rest of Asia-Pacific Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacie
          3. Others
    4. Middle East and Africa
      1. Middle East and Africa Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      2. Middle East and Africa Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Biologics
        2. Corticosteroids
        3. Vitamin D Analogs
        4. Others
      3. Middle East and Africa Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. Middle East and Africa Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacie
        3. Others
      5. UAE Psoriasis Drug Market
        1. UAE Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. UAE Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Biologics
          2. Corticosteroids
          3. Vitamin D Analogs
          4. Others
        3. UAE Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        4. UAE Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacie
          3. Others
      6. Turkey Psoriasis Drug Market
        1. Turkey Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Turkey Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Biologics
          2. Corticosteroids
          3. Vitamin D Analogs
          4. Others
        3. Turkey Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        4. Turkey Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacie
          3. Others
      7. Saudi Arabia Psoriasis Drug Market
        1. Saudi Arabia Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Saudi Arabia Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Biologics
          2. Corticosteroids
          3. Vitamin D Analogs
          4. Others
        3. Saudi Arabia Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        4. Saudi Arabia Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacie
          3. Others
      8. South Africa Psoriasis Drug Market
        1. South Africa Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. South Africa Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Biologics
          2. Corticosteroids
          3. Vitamin D Analogs
          4. Others
        3. South Africa Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        4. South Africa Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacie
          3. Others
      9. Egypt Psoriasis Drug Market
        1. Egypt Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Egypt Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Biologics
          2. Corticosteroids
          3. Vitamin D Analogs
          4. Others
        3. Egypt Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        4. Egypt Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacie
          3. Others
      10. Nigeria Psoriasis Drug Market
        1. Nigeria Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Nigeria Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Biologics
          2. Corticosteroids
          3. Vitamin D Analogs
          4. Others
        3. Nigeria Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        4. Nigeria Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacie
          3. Others
      11. Rest of MEA Psoriasis Drug Market
        1. Rest of MEA Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Rest of MEA Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Biologics
          2. Corticosteroids
          3. Vitamin D Analogs
          4. Others
        3. Rest of MEA Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        4. Rest of MEA Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacie
          3. Others
    5. LATAM
      1. LATAM Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      2. LATAM Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Biologics
        2. Corticosteroids
        3. Vitamin D Analogs
        4. Others
      3. LATAM Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      4. LATAM Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacie
        3. Others
      5. Brazil Psoriasis Drug Market
        1. Brazil Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Brazil Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Biologics
          2. Corticosteroids
          3. Vitamin D Analogs
          4. Others
        3. Brazil Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        4. Brazil Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacie
          3. Others
      6. Mexico Psoriasis Drug Market
        1. Mexico Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Mexico Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Biologics
          2. Corticosteroids
          3. Vitamin D Analogs
          4. Others
        3. Mexico Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        4. Mexico Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacie
          3. Others
      7. Argentina Psoriasis Drug Market
        1. Argentina Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Argentina Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Biologics
          2. Corticosteroids
          3. Vitamin D Analogs
          4. Others
        3. Argentina Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        4. Argentina Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacie
          3. Others
      8. Chile Psoriasis Drug Market
        1. Chile Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Chile Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Biologics
          2. Corticosteroids
          3. Vitamin D Analogs
          4. Others
        3. Chile Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        4. Chile Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacie
          3. Others
      9. Colombia Psoriasis Drug Market
        1. Colombia Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Colombia Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Biologics
          2. Corticosteroids
          3. Vitamin D Analogs
          4. Others
        3. Colombia Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        4. Colombia Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacie
          3. Others
      10. Rest of LATAM Psoriasis Drug Market
        1. Rest of LATAM Psoriasis Drug Market By Class Type 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Rest of LATAM Psoriasis Drug Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Biologics
          2. Corticosteroids
          3. Vitamin D Analogs
          4. Others
        3. Rest of LATAM Psoriasis Drug Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        4. Rest of LATAM Psoriasis Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Retail Pharmacie
          3. Others
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.